Our services

Advance your compounds to the clinic with confidence

We are seasoned specialists in chronic pain and neurodegenerative disease drug discovery with a deep understanding for Client needs. We have a proven track record of developing customer-specific solutions for our Clients to ensure project progress.
Read more arrow_forward
equalizer

We deliver high quality information

We’re not just providing data, we provide valuable information and clear answers to complex biological questions.
fast_forward

We accelerate your decision-making

Thanks to our highly experienced team, proprietary discovery platform and streamlined operations, we can shorten your project lead times.
grid_on

Fast access to ground-breaking assays

We develop highly innovative in vitro assays based on complex biology that provide translationally relevant information.

WORKING WITH US

An approach you can trust

We provide fully collaborative support, tailored to each individual study. Our Clients value our interactive and open communication style, our high capacity, quality and delivery precision needed for projects from target discovery and screening to lead optimization.

Read more

Our platform

Our unique discovery platform

Our team of highly experienced neurobiologists, stem cell researchers and engineers, has developed a unique and patent protected discovery platform which enables development of innovative in vitro assays of enhanced translational value.
Read more arrow_forward

News and events

Latest news and insights

Cellectricon values scientific exchange and we invite you to take part of our latest news, newsletters and to learn about upcoming events.

Read more

News
2020-07-02
Dr. Franziska Denk joins Cellectricon’s advisory board
Cellectricon has appointed Dr. Franziska Denk, Lecturer at the Wolfson Centre for Age-Related Diseases, King’s College London, to its scientific...
Events
June 25, 2020. 8 am PDT / 11 am EDT / 5 pm CEST
Webinar: Neuroinflammation in Chronic Pain – A Case for Interdisciplinary Research
Webinar Description: Neuroinflammation is a major feature of common nervous system disorders, including stroke, neurodegeneration, and chronic pain. And yet,...
News
2020-05-20
Cellectricon’s new neuroinflammation discovery services offer advanced insight into chronic pain
Mölndal, Sweden Cellectricon, a collaborative services provider dedicated to advancing drug discovery and research in the areas of chronic pain...
News
2020-06-04
Advancing pain research through scientific exchange
During the current COVID-19 pandemic many of our fellow researchers see disruption in their work and are prevented from sharing...
News
2020-04-10
COVID-19 update from Cellectricon
In light of the COVID-19 pandemic, we wish to inform you that we remain open for business and are progressing the...
News
2020-02-04
Cellectricon and StressMarq Biosciences collaborate to develop next generation reagents and assays to advance neurodegenerative disease research
Mölndal, Sweden and Victoria, BC, Canada Cellectricon, a collaborative services provider dedicated to advancing drug discovery and research in the...
News
2019-10-15
Towards “disease in a dish” microfluidic models for studying the interaction of bone and neuronal cells
In August, Cellectricon welcomed our new coworker Lydia Moll. Lydia will carry out her PhD project at the company over...
News
2019-02-14
Cellectricon to collaborate with world-renowned pain scientists in the EU-funded Bone Pain Network
Cellectricon, a collaborative services provider dedicated to advance drug discovery and research in the areas of chronic pain and neurodegenerative...

Get the latest news & events – sign up for our newsletter

Read about our Privacy Policy